Unlock this StockReport nowClick to Unlock

Universal Biosensors Inc Share Price

UBI A$0.2 0.0  0.0%

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed 7
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 TTM 2019E 2020E CAGR / Avg
Revenue A$m
Operating Profit A$m
Net Profit A$m
EPS Reported AUD¢
EPS Normalised AUD¢
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps AUD¢
Capex ps AUD¢
Free Cashflow ps AUD¢
Dividend ps AUD¢
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc A$m
Working Capital A$m
Net Fixed Assets A$m
Net Debt A$m
Book Value A$m
Average Shares m
Book Value ps AUD¢ +11.1%

FINANCIAL BRIEF: For the six months ended 30 June 2019, Universal Biosensors, Inc. revenues decreased 71% to A$4M. Net loss increased from A$474K to A$3.5M. Revenues reflect Revenue from services decrease of 87% to A$1.7M. Higher net loss reflects General and administrative increase of 12% to A$4.2M (expense). Basic Earnings per Share excluding Extraordinary Items totaled to -A$0.02. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 30th Jun '19) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2019
31st Dec 2020

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (A$) (¢) (¢) (A$) (¢) (¢)
Consensus Estimate
1m Change
3m Change
1 broker Broker Consensus Trend
Broker Recommendations for Universal Biosensors Inc
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
Taylor Collison ,

Profile Summary

Universal Biosensors, Inc. is a specialist medical diagnostics company. The Company is focused on the research, development and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The Company's subsidiary, Universal Biosensors Pty Ltd, conducts its research, development and manufacturing activities. The Company uses its electrochemical cell technology platform to develop point-of-care testing systems for a range of different markets. The Company is engaged in the development of its own Prothrombin Time International Normalized Ratio (PT-INR) test for use in decentralized settings, including the patient self-test market. It is engaged in demonstrating the various applications of its technology platform, including its application to diagnostic tests based on enzymatic, immunoassay and molecular diagnostic methods. It has developed a blood glucose test with LifeScan, Inc. and a coagulation PT-INR test with Siemens Healthcare Diagnostics Inc.

Directors: Salesh Balak (CEO) 50, Craig Coleman (NEC) 53, Marshall Heinberg (NED) 62, David Hoey (NID) 59, Judith Smith (NID) 63,

No. of Employees: 97 No. of Shareholders: n/a

Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated September 14, 2001
Public Since December 13, 2006
Shares in Issue 177,546,854
Free Float 142.5m (80.3%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Australian Stock Exchange - SEATS
Eligible for an ISA? a SIPP?

UBI Share Price Performance UBI Share Price Quote
0.0  0.0%
Traded 1:00am · Minimum 15 min delayed · NMS:

Latest UBI News Announcements (delayed)

Upcoming UBI Events

Recent ↓
Friday 8th March, 2019
Half Year 2018 Universal Biosensors Inc Earnings Release
Friday 8th March, 2019
Half Year 2018 Universal Biosensors Inc Earnings Call
Tuesday 21st August, 2018
Half Year 2018 Universal Biosensors Inc Earnings Call
Monday 13th August, 2018
Half Year 2018 Universal Biosensors Inc Earnings Release
Friday 23rd March, 2018 (estimate)
Preliminary 2017 Universal Biosensors Inc Earnings Release
Monday 7th August, 2017
Half Year 2017 Universal Biosensors Inc Earnings Release
Monday 7th August, 2017
Interim 2017 Universal Biosensors Inc Earnings Call
Thursday 27th April, 2017
Q1 2017 Universal Biosensors Inc Earnings Release
Wednesday 22nd March, 2017
Preliminary 2016 Universal Biosensors Inc Earnings Release
Tuesday 21st March, 2017
Preliminary 2016 Universal Biosensors Inc Earnings Call
Tuesday 24th January, 2017
Q4 2016 Universal Biosensors Inc Cashflow Reports
Thursday 18th June, 2015
Universal Biosensors Inc at Vertical Events Gold Coast Investment Showcase

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.

Should you buy UBI

Access UBI Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis